Paclitor®
Paclitaxel USP Injection

Brand Name:
Paclitor®30
Generic Name:
Paclitaxel
Strength:
30mg/5mL
Description:
Liquid injection
Pack Size:
1’s

Brand Name:
Paclitor®100
Generic Name:
Paclitaxel
Strength:
100mg/16.7mL
Description:
Liquid injection
Pack Size:
1’s

Brand Name:
Paclitor®300
Generic Name:
Paclitaxel
Strength:
300mg/50mL
Description:
Liquid injection
Pack Size:
1’s
* Storage Conditions: Store below 30 °C temperature. Keep away from light and wet place. Keep out of reach of children.
Approved Indications of Paclitor
- It is indicated as rst-line and subsequent therapy for the treatment of advanced carcinoma of the ovary. As rst-line therapy, It is indicated in combination with cisplatin.
- It is indicated for the adjuvant treatment of node-positive breast cancer administered sequentially to standard doxorubicin-containing combination chemotherapy.
- It is indicated for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy.
- It is in combination with cisplatin, is indicated for the rst-line treatment of non-small cell lung cancer in patients who are not candidates for potentially curative surgery and/or radiation therapy.
- It is indicated for the second-line treatment of AIDS-related Kaposi’s sarcoma.